Stock Code: 000028/200028 Notice No.:2021-34
Short Form of the Stock:SinopharmAccord /Accord B
China NationalAccord Medicines Corporation Ltd.
Summary of Semi-Annual Report 2021
I. Important Notice
The summary of semi-a nnual report is excerpted from the full text of the semi-annual report. For the details , investors should
carefully read the full text of the semi-annual report publis hed on Juchao Information website (www.cninfo.com.cn) and She nzhen
Stock Exchange Website etc., appointed by CSRC.
Other directors attending the Meeting for semi-annualreport deliberation except for the followed
Name of director absent Title for absent director Reasons for absent Attorney
Prompt of modified auditing opinion
□Applicable √ Not applicable
Profit distribution pre-plan of common stock or capitalizing of common reserves pre-plan deliberated by the Board in the reporting
period
□Applicable √ Not applicable
The Company plans not to carry out cash dividend and bonus dis tr ibut ion and capitalizing of common reserves
Profit dis tribution pre-plan of preferred stock deliberated and approved by the Board in the reporting period
□Applicable √ Not applicable
II. Basic informationof the company
1. Company profile
Short form of the stock SinopharmAccord,Accord B Stock code 000028, 200028
Stock exchange for lis t ing Shenzhen Stock Exchange
Person/Way to contact Secretary of the Board Rep. of security affairs
Name Chen Changbing Wang Zhaoyu
Accord Pharm. Bldg., No. 15, Ba Gua Si Accord Pharm. Bldg., No. 15, Ba Gua Si
Office add. Road, Futian District, Shenzhen, Guangdong Road, Futian D istrict, Shenzhen, Guangdong
Province Province
Tel. +(86)755 25875195 +(86)755 25875222
E-mail gyyzinvestor@sinopharm.com gyyz0028@sinopharm.com
2. Main financial data and index
Whether it has retroactive adjustment or re-statement on previous accounting data
□Yes √ No
Increase/decrease in this
Current Period Same period of last year
report y-o-y
Operating revenue (RMB) 33,163,091,887.39 27,169,940,188.52 22.06%
Net profit attributable to shareholders of
the listed Company (RMB) 741,445,013.25 643,451,580.59 15.23%
Net profit attributable to shareholders of
the listed Company after deducting 720,954,408.22 627,017,019.45 14.98%
non-recurring gains and losses (RMB)
Net cash flow aris ing from operating
activities (RMB) 1,229,373,283.57 1,438,204,043.35 -14.52%
Basic earnings per share (RMB/Share)
(note 1) 1.73 1.50 15.33%
Diluted earnings per share (RMB/Share) 1.73 1.50 15.33%
Weighted average ROE 5.22% 4.91% Increase 0.31 percentage p
oints
Increase/decrease in this
End of current period End of last period report-end over that of last
period-end (+,-)
Totalassets (RMB) 44,190,878,403.95 39,594,533,471.65 11.61%
Net assets attributable to shareholder of
listed Company (RMB) 14,346,870,065.79 13,948,322,652.33 2.86%
3. Numberof shareholders and share-holding
Unit: share
Tota lpreference shareholders
Totalcommon shareholders at with voting rights recovered at
period-end 43,600 end of reporting period (if 0
applicable)
Top ten shareholders
Fullname of Nature of Proportion of Amount of Information of shares
查看PDF原文
